Skip to main content
Veterinary Medicines

Prasequine 1 mg tablets for horses

Authorised
  • Pergolide

Product identification

Medicine name:
Prasequine 1 mg tablets for horses
Prasequine, 1 mg tabletid hobustele
Active substance:
  • Pergolide
Target species:
  • Horse (non food-producing)
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Pergolide
    1.00
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Tablet
Withdrawal period by route of administration:
  • Oral use
    • Horse (non food-producing)
      • Not applicable
        no withdrawal period
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QN04BC02
Authorisation status:
  • Valid
Authorised in:
  • Estonia
Package description:
  • Carton box containing 13 OPA/aluminium/PVC-aluminium blisters, containing 7 tablets each
  • Carton box containing 24 OPA/aluminium/PVC-aluminium blisters, containing 10 tablets each
  • Carton box containing 16 OPA/aluminium/PVC-aluminium blisters, containing 10 tablets each
  • Carton box containing 10 OPA/aluminium/PVC-aluminium blisters, containing 10 tablets each
  • Carton box containing 6 OPA/aluminium/PVC-aluminium blisters, containing 10 tablets each

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • CP-Pharma Handelsgesellschaft mbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • CP-Pharma Handelsgesellschaft mbH
Responsible authority:
  • State Agency Of Medicines
Authorisation number:
  • 1091522
Date of authorisation status change:
Reference member state:
  • Netherlands
Procedure number:
  • NL/V/0368/001
Concerned member states:
  • Austria
  • Belgium
  • Czechia
  • Denmark
  • Estonia
  • Finland
  • France
  • Germany
  • Greece
  • Hungary
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Norway
  • Poland
  • Portugal
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

English (PDF)
Published on: 9/05/2023
Updated on: 10/05/2023
Download
Estonian (PDF)
Published on: 31/03/2025

Package Leaflet and Labelling

English (PDF)
Published on: 9/05/2023
Updated on: 10/05/2023
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."